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very limited. Ginkgo biloba extract 761 (EGb 761) is a well-deﬁned
extract obtained from Ginkgo biloba leaves according to a stan-
dardized method. It has been used extensively for the treatment of
diseases related to the memory impairment, stroke, inﬂammation,
and vasooclusive disorders. Consequently, a potential use of EGb
761 in liver ﬁbrosis has been proposed. However, no study has
proved whether EGb 761 can prevent cardiac ﬁbrosis after myocar-
dial infarction. Therefore, this study was performed to investigate
the role of EGb 761 in the myocardial ﬁbrosis in a rat model of
myocardial infarction.
METHODS Adult male SD rats were randomly divided into three
groups: sham group, myocardial infarction group, and myocardial
infarctionþEGb 761 group. According to the doses of EGb 761,
myocardial infarctionþEGb 761 group was divided into three
subgroups: 25 mg/kg, 50 mg/kg, and 100 mg/kg groups. The left
anterior descending coronary artery was permanently ligated in
the myocardial infarction and myocardial infarctionþEGb 761
groups. The sham-operated group was subjected to all procedures
excluding permanent coronary artery ligation. The effects of EGb
761 on the cardiac function and cardiac ﬁbrosis after myocardial
infarction were observed by echocardiography and histological
analyses.
RESULTS Compared with the sham group rats, left ventricular in-
ternal dimension diastole (LVIDd) and left ventricular internal
dimension systole (LVIDs) increased, ejection fraction (EF) and
fractional shortening (FS) decreased in the myocardial infarction
group rats. Notably, LVIDd and LVIDs were signiﬁcantly decreased,
whereas EF and FS were signiﬁcantly improved in the EGb 761
treated rats relative to the myocardial infarction alone rats. Patho-
logical analysis revealed that no blue area and inﬂammatory cell
inﬁltrate was detected in the sham group. In contrast, the infarcted
zone in the myocardial infarction group was ﬁlled with blue scar
tissues. And there were a lot of inﬂammatory cells inﬁltration.
However, administration of EGb 761 reduced the area stained blue
and inﬁltration of inﬂammatory cells compared with myocardial
infarction group. Meanwhile, the effect of 100 mg/kg EGb 761 was
more pronounced.
CONCLUSIONS Our study suggested that EGb 761 could reduce
myocardial ﬁbrosis and improve cardiac function after myocardial
infarction.GW26-e2177
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OBJECTIVES Proprotein convertase subtilisin-like kexin type 9
(PCSK9) gene E670G Polymorphism has been reported to be associated
with coronary artery disease (CAD) and risk factors. However, the
results remain controversial. We sought to perform a meta-analysis to
investigate the relationships between genetic polymorphisms of
PCSK9 gene and the risk of CAD.
METHODS Literature searches were performed to identify all pub-
lished relevant case-control studies without any language restrictions.
Meta-analysis was conducted using the Review Manager software
(version5.2). Heterogeneity was investigated and measured using
Cochran’s Q-statistic and the inconsistency index (I2) test; Crude odds
ratios (OR) with their corresponding 95% conﬁdence interval (CI) were
calculated.
RESULTS A total of 5 case-control studies among 871 patients with
CAD and 1144 control subjects were included in the meta-analysis.
we found a correlation between PCSK9 genetic polymorphisms and
increased risk for CAD under all of the genetic model (allele model:
OR 1.56, 95% CI 1.21-2.01, P < 0.001; dominant model: OR 1.46, 95%
CI 1.14-1.88, P ¼ 0.003; recessive model: OR 3.46, 95% CI 1.19-
10.10, P ¼ 0.02; homozygous model: OR 3.89, 95% CI 1.35-11.20, P ¼
0.01; Heterozygous model: OR 1.43, 95% CI 1.08-1.92, P ¼ 0.01;
respectively).
CONCLUSIONS The results of the meta-analysis indicated that ge-
netic polymorphism of (E670G) SNP in PCSK9 gene was associated
with CAD.GW26-e2249
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OBJECTIVES The oxidative stress play a major role in the pathogen-
esis of acute myocardial infarction (AMI). Early inhibition of oxidative
stress may improve post MI cardiac function. The aim of this study
was to investigate and compare the effects of Panax Notoginseng and
Salvia Miltiorrhiza on cardiac function, infarction size as well as his-
topathologic and electrocardiographic changes in isoproterenol-
induced myocardial infarction.
METHODS Salvianolic Acid B and Tanshinone IIA, Panax Notoginseng
Saponin (20 mg kg-1) were administered to Wistar rats for 14 days. At
the last two days, rats were administered isoproterenol (85mg kg-1)
subcutaneously to induce myocardial infarction. After induction, rats
were anaesthetized with pentobarbital sodium (30 mg kg-1) to record
electrocardiogram and Echocardiographic image, then sacriﬁced and
biochemical assays of the heart tissues were performed.
RESULTS Administration of isoproterenol resulted in myocardial
infarction marked (P <0.05) elevation in J-Point, infarct size, MDA,
protein expression of Bax and a signiﬁcant decrease in the activities of
endogenous antioxidants (SOD) and protein expression of Bcl-2 and
Nrf2. Pretreatment with Salvianolic Acid B and Tanshinone IIA, Panax
Notoginseng Saponin showed a signiﬁcant (P <0.05) decrease in
J-point elevation, infarct size, MDA, protein expression of Bax and a
signiﬁcant increase in the activities of endogenous antioxidants and
protein expression of Bcl-2 and Nrf2 except for Salvianolic Acid B,
where is the major difference between Salvia Miltiorrhiza and Panax
Notoginseng, when compared with ISO groups.
CONCLUSIONS The results of this study showed that pretreatment
with Salvianolic Acid B, Tanshinone IIA and Panax Notoginseng
Saponin strongly protected the myocardium against the isoproter-
enol-induced myocardial injury; where this might be due to the
antioxidative properties of Salvianolic Acid B and Tanshinone IIA,
Panax Notoginseng Saponin.
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OBJECTIVES GP78 is a membrane-anchored ubiquitin ligase medi-
ating the degradation of 3-hydroxy-3-methyl-glutaryl-CoA coenzyme
A reductase (HMGCR) and Insig-1, which was very essential for the
synthesis of cholesterol and glucose process. Dysregulation of lipid
and glucose homeostasis is a risk factor for developing conditions
linked to type 2 diabetes mellitus. The aim of the present study was to
assess the association between the human gp78 gene polymorphism
and type 2 diabetes mellitus (T2DM) in a Han population of China.
METHODS We used case-control studies: a Han population (450 T2DM
patients and 480control subjects). All T2DM patients and controls
were genotyped for the same three single nucleotide polymorphisms
(SNPs) (rs731119, rs2617849and rs2440472) of gp78 gene by a Real-time
PCR instrument.
RESULTS The genotype distributions for each of the SNPs were in
agreement with the predicted Hardy–Weinberg equilibrium values
(data not shown). The distribution of SNP2 (rs2617849) genotypes
showed a signiﬁcant difference between T2DM and control partici-
pants (P¼0.038). the distribution of SNP2 (rs2617849) alleles and the
dominant model (TT vs CCþCT) showed a signiﬁcant difference be-
tween T2DM and control participants (for allele: P¼0.021; for domi-
nant model: P¼0.017 ). T allele of rs2617849 was signiﬁcantly higher in
T2DM patients than in control participants (73% vs 62.5%). And the C
allele of rs2617849 was signiﬁcantly lower in T2DM patients than in
control participants (27% vs 37.5). The dominant model (TTvsCCþCT)
of rs2617849 was signiﬁcantly higher in T2DM patients than in control
participants (57.8% vs 45.8%). The signiﬁcant difference of rs2617849
was retained after adjustment for EH, BMI, LDL, and smoking.
(OR: 1.461, 95% conﬁdence interval [CI]: 1.084-1.991, P¼0.032).
